MacroGenics, Inc. (MGNX)
$3.31-3.22%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $210M
- Beta
- 1.21
- P/E (TTM)
- -15.05
- Short % float
- 12.60%
- Days to cover
- 10.9
- SI change
- +0.1%
- 1W
- -6.76%
- 1M
- -18.07%
- vs SPY 1W
- -5.78%
- vs SPY 1M
- -19.93%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MGNX?
- LOPJLB’s latest quantitative signal on MacroGenics, Inc. (MGNX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MGNX in?
- MacroGenics, Inc. (MGNX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does MacroGenics, Inc. (MGNX) do?
- MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The companyâs product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical…